IPC International Fellowship Program
FOSTERING THE NEXT GENERATION OF PSORIASIS LEADERS
IPC’s International Fellowship program provides young dermatologists and researchers interested in psoriasis full access to the knowledge of our network of experts and represents our commitment to cultivating expertise in the field.
GOALS
- Encourage and educate early-career dermatologists to treat psoriasis as a systemic disease with significant comorbidities.
- Expose early-career dermatologists to key opinion leaders and encourage their participation in projects and dialogue that furthers the advancement of psoriasis research and treatment globally.
- Connect and strengthen early-career commitment to the field of psoriasis research and treatment.
The project is led by the Fellowship Program Advisory Committee.
Project Description
Awarded fellows are matched with IPC Board Members or Councilors to observe and participate in clinical practice and laboratory research of patients with psoriasis. This opportunity provides real-world practice in the investigation, diagnosis, and development of treatment plans for psoriasis. In addition, the program provides an opportunity for IPC Fellows to develop ongoing relationships with key opinion leaders by participating in IPC programs and activities throughout a one-year period.
The application window for 2024 Fellowships is now closed. Fellowship awards will be announced in early November.
2023 IPC Fellows
Sonia
Chavez-Alvarez
,
MD
Hospital Universitario Dr. José Eleuterio Gonzalez – UANL
Monterrey, Nuevo León
,
Mexico
2023 Fellow
Maria-Angeliki
Gkini
,
MD, MSc, PhD
401 General Army Hospital, Athens, Greece and Barts Health NHS Trust, London
London
,
United Kingdom
2023 Fellow
Mio
Nakamura
,
MD, MS, FAAD
University of Michigan
Ann Arbor
,
Michigan
,
United States
2023 Fellow
The 2023 IPC International Fellowship Program is supported in part by Bristol Myers Squibb and Janssen Biotech, Inc.
Get in Touch With IPC
Subscribe to the IPC Newsletter
We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.
